OnKure Therapeutics, Inc. Research And Development Expense

• OnKure Therapeutics, Inc. showed an increase of +10.2% in Research And Development Expense from 2024 to 2025.
• This data is from OnKure Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), OnKure Therapeutics, Inc.'s Research And Development Expense has grown by 202.7%.
• Historical annual values: Fiscal year 2025: $48.26 million | Fiscal year 2024: $43.80 million | Fiscal year 2023: $32.12 million | Fiscal year 2022: $37.71 million | Fiscal year 2021: $28.17 million | Fiscal year 2020: $15.94 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026